Patent Assignment
Reel/Frame 059250/0619
Assignment of Assignor's Interest
Recorded: 2022-03-14
Pages: 5
Assignor
SHIRE HUMAN GENETIC THERAPIES, INC.
Executed: 2021-02-26
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-0045, JAPAN
Covered Property
(1)
Inhibitors of Plasma Kallikrein and Uses Thereof
PCT:
PCT/US2019/021897 ↗
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 26, 2019
From: RAE, ALASTAIR; ELLARD, JOHN MARK
To: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
Reel/Frame 049600/0497 →
Assignment of Assignor's Interest
Jun 26, 2019
From: PAPAIOANNOU, NIKOLAOS; MILLER, THOMAS ALLEN; SHIPPS, GERALD WAYNE, JR.; TRAVINS, JEREMY MARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 049600/0536 →
Assignment of Assignor's Interest
Jun 26, 2019
From: FINK, SARAH JOCELYN
To: BIODURO LLC
Reel/Frame 049600/0552 →
Assignment of Assignor's Interest
Jun 26, 2019
From: BIODURO LLC
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 049600/0564 →
Assignment of Assignor's Interest
Jun 26, 2019
From: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: CHARLES RIVER LABORATORIES, INC.
Reel/Frame 049600/0583 →
Assignment of Assignor's Interest
Jun 26, 2019
From: CHARLES RIVER LABORATORIES, INC.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 049600/0587 →